Talal Dahhan is a Respiratory physician affiliated with University of Massachusetts Chan Medical School. OpenAlex indexes 52 publications with 466 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3300 Main Street
2nd Fl, Suite B
Springfield, MA 011071112
Telephone
413-794-7330Provider last certified this registry record 25 Apr 2024.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- United Therapeutics CorporationProgram year20252 payments
- Merck Sharp & Dohme LLCProgram year20251 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
32.1%Endothelin Receptor Antagonist17.2%Opsumit66%Ambrisentan21%Letairis13%Part D<11 patientsLoop diuretic7.7%Torsemide58%Furosemide42%Part D<11 patients+ 3 more classes in this area
Respiratory
23.4%Corticosteroid10.3%Trelegy Ellipta78%Breo Ellipta22%Part D<11 patientsHistamine-1 Receptor Antagonist5.9%Levocetirizine Dihydrochloride75%Azelastine Hcl25%Part D<11 patients+ 3 more classes in this area
Blood & clotting
17.7%Factor Xa inhibitor10.5%Eliquis100%Part D≥20 patientsProstacyclin Receptor Agonist5.5%Uptravi100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 1122: AUTOMATED ABSTRACTION OF PULMONARY EMBOLISM CONCEPTS FROM CT REPORTS WITH LARGE LANGUAGE MODELS
Critical Care Medicine
2025 - Consultation and Echocardiography Timing for Duke Health Patients With Pulmonary Embolism Diagnosed Via Computed Tomography
American Journal of Respiratory and Critical Care Medicine
2025 - Regional Variation of Pulmonary Arterial Hypertension Mortality in the United Stated. A CDC Wonder Study
American Journal of Respiratory and Critical Care Medicine
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Fernando Martinez, MD
University of Massachusetts Chan Medical School
Richard Irwin, MD
University of Massachusetts Chan Medical School
Kimberly Yonkers, MD
University of Massachusetts Chan Medical School
Craig Lilly, MD
University of Massachusetts Chan Medical School
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”